Kyowa Kirin Co Ltd

JP

KYHAK

Health Care

19.8 ₽

Current price

Sell
19.8 ₽

Target price 00%

Ranks rating

76

  • Position in sub-industry

    370 / 1328

  • Position in country

    2428 / 4811

  • Return on Assets, %

    8.2

    -2.7

  • Net income margin, %

    20.2

    2.8

  • EBITDA margin, %

    32.3

    10.8

  • Debt to Equity, %

    2.3

    19.2

  • Intangible assets and goodwill, %

    19.8

    3.6

  • Revenue CAGR 3Y, %

    11.5

    8.5

  • Total Equity change 1Y, %

    1.9

    0

  • Revenue Y, % chg

    4.1

    0.5

  • P/E

    17.7

    22.7

  • P/BV

    1.7

    1.5

  • P/S

    3.2

    2.3

  • EV/S

    2.4

    2.4

  • EV/EBITDA

    8.9

    7.4

  • Average Analyst recommendation

    Hold

    Hold

  • Average upside forecasts, %

    2.3

    51.3

  • Forward P/E

    21

    15.6

  • Dividend Yield, %

    1.9

    1.7

  • Forward Dividend Yield, %

    1.9

    0.2

  • Expected dividend per share

    0.3

    0

  • Payout Ratio, %

    37

    30.3

Get an analytical review of this company

Competitors

Ranks

  • Daiichi Sankyo Co Ltd

    00%

  • Ono Pharmaceutical Co Ltd

    00%

  • Kyowa Kirin Co Ltd

    00%

  • Shionogi & Co Ltd

    00%

  • Taisho Pharmaceutical Holdings Co Ltd

    00%

  • Chugai Pharmaceutical Co Ltd

    00%

  • Takeda Pharmaceutical Co Ltd

    00%

  • Eisai Co Ltd

    00%

  • Otsuka Holdings Co Ltd

    00%

  • Astellas Pharma Inc

    00%

Ready-made portfolio of the best Russian stocks

  • Created by artificial intelligence
  • Verified by analysts
  • Available even to beginners

Company information

  • Country

    Japan

  • Sector

    Health Care

  • Industry group

    Pharmaceuticals, Biotechnology & Life Sciences

  • Industry

    Pharmaceuticals

  • Sub-sector

    Health Care

  • Capitalization (millions of $)

    9447.4

  • Ticker

    KYKOY.PK

  • ISIN

    US50156R1077

  • IPO date

    1949-08-22

  • Availability on Russian exchanges

    No

  • Reporting for

    2024-03-12

  • Date fact. publication of reports

    2023-12-31

Company Description

Kyowa Kirin Co., Ltd., formerly Kyowa Hakko Kirin Co., Ltd. is a Japan-based company principally engaged in the manufacture and sale of medical drugs. The Company operates through two business segments. Pharmaceuticals segment conducts research, development, manufacture and sale of pharmaceuticals and other products. Bio-chemicals segment is involved in the research, development, manufacture and sale of pharmaceuticals and industrial raw materials mainly for amino acid and nucleic acid related substances, as well as healthcare products.

A step towards better analytics

  • find the best promotions through the Screener
  • keep an eye on stock valuation
  • download detailed reports

and much more after free registration

Registration

More convenient from your phone? Download: